Communication in the context of glioblastoma treatment: A qualitative study of what matters most to patients, caregivers and health care professionals. (June 2023)
- Record Type:
- Journal Article
- Title:
- Communication in the context of glioblastoma treatment: A qualitative study of what matters most to patients, caregivers and health care professionals. (June 2023)
- Main Title:
- Communication in the context of glioblastoma treatment: A qualitative study of what matters most to patients, caregivers and health care professionals
- Authors:
- Boele, Florien W
Butler, Sean
Nicklin, Emma
Bulbeck, Helen
Pointon, Lucy
Short, Susan C
Murray, Louise - Abstract:
- Background: Patients with glioblastoma have a poor prognosis and treatment is palliative in nature from diagnosis. It is therefore critical that the benefits and burdens of treatments are clearly discussed with patients and caregivers. Aim: To explore experiences and preferences around glioblastoma treatment communication in patients, family caregivers and healthcare professionals. Design: Qualitative design. A thematic analysis of semi-structured interviews. Setting/participants: A total of 15 adult patients with glioblastoma, 13 caregivers and 5 healthcare professionals were recruited from Leeds Teaching Hospitals NHS Trust. Results: Four themes were identified: (1) Communication practice and preferences . Risks and side-effects of anti-tumour treatments were explained clearly, with information layered and repeated. Treatment was often understood to be 'the only option'. Understanding the impact of side-effects could be enhanced, alongside information about support services. (2) What matters most . Patients/caregivers valued being well-supported by a trusted treatment team, feeling involved, having control and quality of life. Healthcare professionals similarly highlighted trust, maintaining independence and emotional support as key. (3) Decision-making . With limited treatment options, trust and control are crucial in decision-making. Patients ultimately prefer to follow healthcare professional advice but want to be involved, consider alternatives and voice what mattersBackground: Patients with glioblastoma have a poor prognosis and treatment is palliative in nature from diagnosis. It is therefore critical that the benefits and burdens of treatments are clearly discussed with patients and caregivers. Aim: To explore experiences and preferences around glioblastoma treatment communication in patients, family caregivers and healthcare professionals. Design: Qualitative design. A thematic analysis of semi-structured interviews. Setting/participants: A total of 15 adult patients with glioblastoma, 13 caregivers and 5 healthcare professionals were recruited from Leeds Teaching Hospitals NHS Trust. Results: Four themes were identified: (1) Communication practice and preferences . Risks and side-effects of anti-tumour treatments were explained clearly, with information layered and repeated. Treatment was often understood to be 'the only option'. Understanding the impact of side-effects could be enhanced, alongside information about support services. (2) What matters most . Patients/caregivers valued being well-supported by a trusted treatment team, feeling involved, having control and quality of life. Healthcare professionals similarly highlighted trust, maintaining independence and emotional support as key. (3) Decision-making . With limited treatment options, trust and control are crucial in decision-making. Patients ultimately prefer to follow healthcare professional advice but want to be involved, consider alternatives and voice what matters to them. (4) Impact of COVID-19 . During the pandemic, greater efforts to maintain good communication were necessary. Negative impacts of COVID-19 were limited, caregivers appeared most disadvantaged by pandemic-related restrictions. Conclusions: In glioblastoma treatment communication, where prognosis is poor and treatmentwill not result in cure, building trusting relationships, maintaining a sense of control and being well-informed are identified as critical. … (more)
- Is Part Of:
- Palliative medicine. Volume 37:Number 6(2023)
- Journal:
- Palliative medicine
- Issue:
- Volume 37:Number 6(2023)
- Issue Display:
- Volume 37, Issue 6 (2023)
- Year:
- 2023
- Volume:
- 37
- Issue:
- 6
- Issue Sort Value:
- 2023-0037-0006-0000
- Page Start:
- 834
- Page End:
- 843
- Publication Date:
- 2023-06
- Subjects:
- Brain tumour -- glioblastoma -- caregivers -- communication -- decision-making -- palliative care
Pain -- Treatment -- Periodicals
Cancer -- Palliative treatment -- Periodicals
Palliative Care -- Periodicals
Palliatieve behandeling
616.029 - Journal URLs:
- http://pmj.sagepub.com/ ↗
http://www.uk.sagepub.com/home.nav ↗
http://www.ingenta.com/journals/browse/arn/pm ↗ - DOI:
- 10.1177/02692163231152525 ↗
- Languages:
- English
- ISSNs:
- 0269-2163
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26759.xml